This month, a paper published by University researchers Richard Terek and Qian Chen highlighted a potential nanotechnology therapy that targets chondrosarcoma, a rare type of bone cancer. Using nanoparticles, the team effectively delivered therapies directly into tumor cells and observed decreases in tumor volume and prolonged survival in mouse models.
Chondrosarcoma currently has no FDA approved treatments. The complex makeup of these cancer cells makes them uniquely difficult to treat. Specifically, one challenge to (drug) delivery in chondrosarcoma is the negatively charged proteoglycan-rich extracellular matrix that needs to be penetrated to reach the tumor cells, according to the study.
Terek, the chief of musculoskeletal oncology at Rhode Island Hospital, an orthopedic oncology surgeon with the Lifespan Cancer Institute and a professor of orthopedic surgery at Warren Alpert, studies chondrosarcoma and collaborated with Chen, a molecular and nano-medicine researcher, director of the NIH-funded Center of Biomedical Research Excellence in Skeletal Health and Repair at Rhode Island Hospital and a professor of orthopedic research and medical science, on this study. The pair aimed to develop a nanopiece delivery platform capable of penetrating the convoluted chondrosarcoma matrix.
We develop nanomaterial (that) we call nanopieces and we found that it can deliver nucleic acid therapeutics to tissues that normally are very difficult to be penetrated, Chen said.
In addition to getting drugs to the tumor tissue, the researchers also studied the biology of how chondrosarcoma spreads. The other thing is we dont totally understand what drives cancer cells to metastasize. That part of the work involves trying to disentangle which types of pathways have gone awry, Terek said.
The underlying principle of the therapy is that miRNA, short 21-nucleotide sequences, are overexpressed in chondrosarcoma tumor cells. These miRNA end up functioning in a way similar to oncogenes, genes which drive cancer formation, by indirectly affecting other genes in the cancer pathway.
Tereks work over the past decade has culminated in the identification of the cancer-causing, or oncogenic, miRNA involved in chondrosarcoma formation. That process involved microarray analysis of primary human tumor tissues. We used a variety of screening techniques to identify which miRNA were overexpressed in tumors, Terek said.
These detrimental effects of the oncogenic miRNA can be prevented by synthesizing a molecule of the opposite sequence of nucleotides. Once delivered into the cell with the nanoparticles it will counteract and annihilate the overexpressed miRNA Terek said.
Once the target miRNA was identified, the small, opposing sequence of RNA needed to be delivered, a process that is normally very difficult because of the charge and structure of the matrix formed by the tumor. What we do in the lab is formulate this nanomaterial specifically for penetrating into the matrix, Chen said.
The laws kind of break down when you get to these nano levels. At the nano level, these particles somehow get through the cell wall and into the cell, even though the cell wall is classically thought of as this impenetrable structure around the cell, Terek said.
The nanomaterial delivery vehicle is composed of a small molecule, weighing about 400 daltons, which assembles into a nanotube structure that contains RNA. The molecule itself is biomimetic. Its half composed of nucleic bases and half of the molecule is amino acids, so its fused together. Because of that it also has a very low level of cell toxicity, Chen said. The nanoparticle is designed to be comparable to a natural biological structure, enabling the particle to be generally accepted by cells, so it can enter and affect them.
In previous studies, Chens lab has shown successful use of nanoparticle therapy in the treatment of multiple other diseases, including rheumatoid arthritis. Recently, they also received a grant from the National Institutes of Health funding research on the treatment of Alzheimers disease using a similar nanopiece delivery system that can traverse the blood brain barrier.
In further developing this drug therapy, Terek said one possibility is to combine multiple miRNA sequences with these nanoparticles to impact more pathways and get maximal inhibition of tumor spread. This involves both counteracting overexpressed miRNA, and restoring beneficial cancer suppressor miRNAs to combine multiple therapeutics with one dose of the nanoparticles.
Another potential approach is to pair the miRNA therapy with other cancer drug therapies. Since some miRNAs prevent the effective use of typical cancer treatment drugs, this approach can be used to reverse drug resistance, allowing for the use of conventional therapies, like chemotherapy.
In order for nanoparticle therapy development to succeed, investors, pharmaceutical companies, biotech companies and other collaborators need to give time and money to projects like this, Chen said. As far as moving it into the clinic, thats always a big hurdle, Terek said. One intermediate step the team might take is to collaborate with veterinarians allowing them to incorporate their treatment method beyond mouse models.
Brown and Lifespan have helped establish a startup called NanoDe so that we can continue the process, Chen said. Moving forward, the team will continue to work on collaborating with other researchers and developers to advance this drug therapy for chondrosarcoma.
Read the rest here:
- 'Laser tweezers' in nano lab used in search for drug to prevent COVID-19 replication - The Province - May 3rd, 2020
- Missouri Indian American Professor Develops Disinfecting Tunnel to Kill Viral Infections Using Silver Nano-particles - India West - May 3rd, 2020
- Triple Negative Breast Cancer Treatment Market to Grow at Stellar CAGR Double In% During the Forecast Period 2026 - Cole of Duty - May 3rd, 2020
- PDF | What Is The Impact Of COVID 19 On Nano-Silicon Dioxide Market? | Eon Market Research Analysis Report 2020 - MR Invasion - May 3rd, 2020
- What is Nanomedicine? : Center for Nanomedicine - March 31st, 2020
- Nanomedicine | medicine | Britannica - March 31st, 2020
- Nano Medicine: Meaning, Advantages and Disadvantages - March 31st, 2020
- Nanomedicine: Nanotechnology, Biology and Medicine ... - March 31st, 2020
- What Might be the Best Way to Delivery Nanoparticle Therapy for Cancer? - Genetic Engineering & Biotechnology News - March 31st, 2020
- Nano Healthcare Technology For Medical Equipment Market Business Opportunities, 2020 Trends, Challenges and Standardization, Research, Key Players and... - March 31st, 2020
- Global Healthcare Nanotechnology Market 2019 Present Status and Future Opportunities by Major Companies Typs and Applications 2024 - The Fuel Fox - March 31st, 2020
- Nanobiotix 2019 Q4 and Annual Revenues - BioSpace - February 29th, 2020
- Dying Of Flu, College Student Used Cellphone To Call 911. He Died When Police Couldn't Find His Location. - Kaiser Health News - February 29th, 2020
- Clene Nanomedicine Announces First Patient Dosed in the RESCUE-ALS Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with Lead... - January 25th, 2020
- Modifying ICCA with Trp-Phe-Phe to Enhance in vivo Activity and Form N | IJN - Dove Medical Press - January 25th, 2020
- Biomedical Applications of Zeolitic Nanoparticles, with an Emphasis on | IJN - Dove Medical Press - January 25th, 2020
- Nanocarriers for Stroke Therapy: Advances and Obstacles in Translating | IJN - Dove Medical Press - January 25th, 2020
- Healthcare Nanotechnology (Nanomedicine) Market Share, Size, Future Demand, Global Research, Top Leading Player, Emerging Trends and Forecast to 2015 ... - January 25th, 2020
- Advancells Group & IFC Concluded their 3-Day Workshop on Regenerative Medicine - Business Wire India - January 25th, 2020
- I asked Tanzanians about studying in China: here's what they said - The Conversation Africa - January 25th, 2020
- The Future Of Nano Medicine - January 19th, 2020
- New Approaches in Breast Cancer Therapy Through Green Nanotechnology a | IJN - Dove Medical Press - January 19th, 2020
- Controlled phage therapy hints at future alternative to antibiotics - New Atlas - January 19th, 2020
- A New Old Therapy - The UCSB Current - January 19th, 2020
- Most engineered nanoparticles enter tumours through cells not between them, U of T researchers find - News@UofT - January 19th, 2020
- Canterbury father and son's invention will revolutionise medical treatment - Stuff.co.nz - December 28th, 2019
- Rewind 2019: A Look Back at Significant Developments in Indian Science This Year - The Weather Channel - December 27th, 2019
- Electroplating method makes conductive nanostraws for injecting into and sampling from cells - Chemical & Engineering News - December 3rd, 2019
- Protein-Protected Metal Nanoclusters That Behave Like Natural Enzymes - Advanced Science News - December 3rd, 2019
- Design and Synthesis of Gold-Gadolinium-Core-Shell Nanoparticles as Co | IJN - Dove Medical Press - December 3rd, 2019
- Biochips Technologies, Companies, Applications & Markets, 2028 - 94 Companies are Included Along with a Listing of 121 Collaborations Between... - December 3rd, 2019
- Invicro LLC Joins Accenture's INTIENT Network to Help Advance Innovation in Drug Discovery and Scientific Research - BioSpace - December 3rd, 2019
- At 9.6% CAGR, Healthcare Nanotechnology Market Global Industry to Reach Valuation over 306100 Million USD by 2025 - Markets Gazette 24 - November 22nd, 2019
- Nanotherapies for Rheumatoid Arthritis: Advantages, Challenges, and Future Direction - Rheumatology Advisor - November 22nd, 2019
- World Pancreatic Cancer Day: increasing awareness and inspiring action - UNSW Newsroom - November 22nd, 2019
- Bankrupt biopharmas are rare. 2019 has some worried that's changing. - BioPharma Dive - November 22nd, 2019
- Healthcare Nanotechnology Market Needs and Demand Analysis 2019 to 2025 - The Chicago Sentinel - November 13th, 2019
- Medical equipment to be infection-free now, says study - Zee News - November 12th, 2019
- Advances in nanomedicine for the treatment of ankylosing spondylitis | IJN - Dove Medical Press - November 1st, 2019
- Market Share in Nanotechnology and Nanomedicine for Treatment of Viral Infections Could Reach Tens of Billion Dollars - P&T Community - November 1st, 2019
- A highly biocompatible and intravenous injectable hafnium oxide nanocrystal synthesized to enhance radiaotherapy efficacy for cancer treatment -... - November 1st, 2019
- Doheny and UCLA Stein Eye Institutes Welcome Kaustabh Ghosh, PhD, to the Scientific and Clinical Research Faculty - PRNewswire - November 1st, 2019
- SUNY Potsdam chemistry professor awarded grant from National Institutes of Health - NNY360 - October 1st, 2019
- Improving 131I Radioiodine Therapy By Hybrid Polymer-Grafted Gold Nano | IJN - Dove Medical Press - October 1st, 2019
- MagForce AG to host Lunch Symposium on Local Therapies in Malignant Gliomas during the 19th European Congress of Neurosurgery (EANS2019) - BioSpace - October 1st, 2019
- Synthetic networks with tunable responsiveness, biodegradation, and molecular recognition for precision medicine applications - Science Advances - October 1st, 2019
- Self-Assembly Of Retinoid Nanoparticles For Melanoma Therapy | IJN - Dove Medical Press - October 1st, 2019
- Nanomanipulator Market Upcoming Trends, Revenue, Key Manufactures and Competitive Analysis till 2025 - One Digi Click - October 1st, 2019
- First-of-its-kind trial in ALS spurs hope for brutal disease - BioPharma Dive - October 1st, 2019
- FBI Investigation Targets Trump Booster Peter Thiel’s VC Firm - September 14th, 2019
- YouTube Influencers Are Mentally Collapsing From Stress - September 14th, 2019
- Watch SpaceX Test Its Crew Dragon’s Escape System - September 14th, 2019
- MIT Team “Accidentally” Invents Blackest Material in Existence - September 14th, 2019
- A Driver Tricked Uber’s Algorithm, Sexually Assaulted a Passenger - September 14th, 2019
- Toyota Wants to Slather Solar Panels All Over Its Prius Hybrid - September 14th, 2019
- A Runaway Star Is Escaping a Black Hole at 1.2 Million MPH - September 14th, 2019
- Putin Critic Uses Drone to Save Hard Drives Before Police Raid - September 14th, 2019
- Airbus Planes Will Track How Often Passengers Go to the Bathroom - September 14th, 2019
- Watch a Robot Fish Fly by Shooting Water out of Its Rear - September 14th, 2019
- Residents Are Trying to Flee Russian Town Where Snow Turned Black - September 14th, 2019
- This Startup Will Send DNA From Your Spit to the Moon for $99 - September 14th, 2019
- Horrifying Study: Corpses Thrash Around For a Year After Death - September 14th, 2019
- French Gov Official Warns Facebook: Libra Is Not Welcome Here - September 14th, 2019
- Watch a Tesla Model X Blast Through Deep Flood Waters - September 14th, 2019
- Milky Way’s Giant Black Hole Lets out Two Giant, Radioactive Burps - September 14th, 2019
- Instagram Keeps Accidentally Flagging Fish Photos as Offensive - September 14th, 2019
- MIT Community Horrified by Famed Researcher’s Epstein Outburst - September 14th, 2019
- Unlike MIT, Harvard Cut Off Epstein Donations After Conviction - September 14th, 2019
- Can You Tell Which of These Models Is CGI? - May 28th, 2019
- We Asked an AI to Finish Real Elon Musk Tweets - May 28th, 2019
- Watch a Super-Strong Robot Dog Pull a Three-Ton Airplane - May 28th, 2019
- Asteroid Flying by Earth Is so Big It Has Its Own Moon - May 28th, 2019
- United Nations: Siri and Alexa Are Encouraging Misogyny - May 28th, 2019
- New Law Could End Robocalling Once and For All - May 28th, 2019
- Scientists Set New Temperature Record for Superconductivity - May 28th, 2019
- Elevate Your Leadership and Grow Your Business at Your Clouds Can 2019 - May 28th, 2019
- NASA’s Moon Mission Leader Just Quit After Only Six Weeks - May 28th, 2019
- Watch a Tesla in an Underground Tunnel Race One on the Street - May 28th, 2019
- SpaceX Just Unleashed 60 Starlink Satellites Into Orbit - May 28th, 2019
- Elon Musk Ridicules Jeff Bezos’ Plan For Space Colonies - May 28th, 2019